Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.41 |
| ▸ | DGAT1 | O75907 | 4/20 | 0.39 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.37 |
| ▸ | F2R | P25116 | 1/20 | 0.35 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.35 |
| ▸ | PLG | P00747 | 1/20 | 0.35 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.35 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | NPY1R | P25929 | 1/20 | 0.33 |
| ▸ | TTR | P02766 | 1/20 | 0.33 |
| ▸ | IL2 | P60568 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20016562 | 0.85 | TTR (0.45) | FOLH1DGAT1F2RL1F2RKLKB1 | |
| SCHEMBL24335147 | 0.84 | TTR (0.43) | FOLH1DGAT1F2RL1F2RKLKB1 | |
| SCHEMBL22969740 | 0.84 | TTR (0.38) | FOLH1DGAT1F2RL1F2RKLKB1 | |
| SCHEMBL29351004 | 0.84 | TTR (0.46) | FOLH1DGAT1F2RL1F2RKLKB1 | |
| SCHEMBL26412265 | 0.83 | TTR (0.42) | FOLH1F2RL1F2RKLKB1PLG | |
| SCHEMBL23180460 | 0.83 | TTR (0.37) | FOLH1DGAT1F2RL1F2RKLKB1 | |
| SCHEMBL24176337 | 0.82 | TTR (0.37) | FOLH1F2RL1F2RKLKB1PLG | |
| SCHEMBL25204552 | 0.81 | TTR (0.46) | FOLH1DGAT1F2RL1F2RKLKB1 | |
| SCHEMBL25100412 | 0.81 | FOLH1 (0.39) | FOLH1DGAT1NPY1R | |
| SCHEMBL12342504 | 0.80 | TTR (0.44) | FOLH1F2RKLKB1PLGTTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3024460-B1 | METHOD FOR PRODUCING ANTIBODY-SN-38 IMMUNOCONJUGATES WITH A CL2A LINKER | IMMUNOMEDICS INC (US) | 2020-07-22 | — | — | EP | disclosed |